Genetics of type 1 diabetes

Endocrinology and Metabolism Clinics of North America

Volumn 33, Issue 1, 2004, Pages 1-16

  Alberto, Pugliese ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA DQ ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; INSULIN;

ANTIGEN PRESENTATION; AUTOIMMUNITY; BETA CHAIN; CHROMOSOME 2Q; CYTOTOXIC T LYMPHOCYTE; DIABETOGENESIS; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC HETEROGENEITY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HERITABILITY; HLA SYSTEM; HUMAN; HUMAN GENOME; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MICROSATELLITE INSTABILITY; NONHUMAN; PEDIGREE; POLYMORPHIC LOCUS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TANDEM REPEAT;

ALLELES; ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MICE; MINISATELLITE REPEATS;

EID: 1842579286     PISSN: 08898529     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8529(03)00082-3     Document Type: Review

References (72)

1. Redondo M.J., Yu L., Hawa M., Mackenzie T., Pyke D.A., Eisenbarth G.S., et al. Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States. Diabetologia. 44:(3):2001;354-362.
2. Onengut-Gumuscu S., Concannon P. Mapping genes for autoimmunity in humans: type 1 diabetes as a model. Immunol Rev. 190:2002;182-194.
3. Verge C.F., Vardi P., Babu S., Bao F., Erlich H.A., Bugawan T., et al. Evidence for oligogenic inheritance of type 1 diabetes in a large Bedouin Arab family. J Clin Invest. 102:(8):1998;1569-1575.
4. Davies J.L., Kawaguchu Y., Bennett S.T., Copeman J.B., Cordell H.J., Pritchard L.E., et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature. 371:1994;130-136.
5. Concannon P., Gogolin-Ewens K.J., Hinds D.A., Wapelhorst B., Morrison V.A., Stirling B., et al. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet. 19:(3):1998;292-296.
6. Mein C.A., Esposito L., Dunn M.G., Johnson G.C.L., Timms A.E., Goy J.V., et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet. 19:1998;297-300.
7. Cox N.J., Wapelhorst B., Morrison V.A., Johnson L., Pinchuk L., Spielman R.S., et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiplex families. Am J Hum Genet. 69:(4):2001;820-830.
8. Noble J.A., Valdes A.M., Cook M., Klitz W., Thomson G., Erlich H.A. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet. 59:1996;1134-1148.
9. Dorman J.S., Bunker C.H. HLA-DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review. Epidemiol Rev. 22:(2):2000;218-227.
10. Khalil I., Deschamps I., Lepage V., Al-Daccak R., Degos L., Hors J. Dose effect of Cis- and trans-encoded HLA-DQ alpha/beta heterodimers in IDDM susceptibility. Diabetes. 41:1992;378-384.
11. Pugliese A. Genetic protection from insulin-dependent diabetes mellitus. Diabetes Nutr Metab. 10:1997;169-179.
12. *0102 is attenuated with age at onset. Swedish Childhood Diabetes Study Group. Eur J Immunogenet. 26:(2-3):1999;117-127.
13. Hagopian W.A., Sanjeevi C.B., Kockum I., Landin-Olsson M., Karlsen A.E., Sundkvist G., et al. Glutamate decarboxylase-, insulin-, islet cell antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest. 95:1995;1505-1511.
14. *0602 is associated with dominant protection from diabetes even among islet cell antibody positive first degree relatives of patients with insulin-dependent diabetes. Diabetes. 44:1995;608-613.
15. *0602: identification by the Diabetes Prevention Trial - Type 1. J Clin Endocrinol Metab. 85:(3):2000;1255-1260.
16. *. J Clin Endocrinol Metab. 85:(10):2000;3793-3797.
17. Nerup J., Platz P., Andersen O.O., Christy M., Lyngsoe J., Poulsen J.E., et al. HL-A antigens and diabetes mellitus. Lancet. 2:(7885):1974;864-866.
18. Valdes A.M., Thomson G., Erlich H.A., Noble J.A. Association between type 1 diabetes age of onset and HLA among sibling pairs. Diabetes. 48:(8):1999;1658-1661.
19. Demaine A.G., Hibberd M.L., Mangles D., Millward B.A. A new marker in the HLA class I region is associated with the age at onset of IDDM. Diabetologia. 38:(5):1995;623-628.
20. Fennessy M., Metcalfe K., Hitman G.A., Niven M., Biro P.A., Tuomilehto J., et al. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group. Diabetologia. 37:(9):1994;937-944.
21. Langholz B., Tuomilehto-Wolf E., Thomas D., Pitkaniemi J., Tuomilehto J. Variation in HLA-associated risks of childhood insulin-dependent diabetes in the Finnish population: I. Allele effects at A, B, and DR loci. Childhood Diabetes in Finland (DiMe) study group. Genet Epidemiol. 12:(5):1995;441-453.
22. Honeyman M.C., Harrison L.C., Drummond B., Colman P.G., Tait B.D. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol Med. 1:(5):1995;576-582.
23. Lie B.A., Todd J.A., Pociot F., Nerup J., Akselsen H.E., Joner G., et al. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet. 64:(3):1999;793-800.
24. Moghaddam P.H., de Knijf P., Roep B.O., Van der Auwera B., Naipal A., Gorus F., et al. Genetic structure of IDDM1. Two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Diabetes. 47:1998;263-269.
25. Gambelunghe G., Ghaderi M., Cosentino A., Falorni A.D., Brunetti P., Falorni A.L., et al. Association of MHC class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia. 43:2000;507-514.
26. Bilbao J.R., Martin-Pagola A., Calvo B., Perez D.N., Gepv N., Castano L. Contribution of MIC-A polymorphism to type 1 diabetes mellitus in Basques. Ann N Y Acad Sci. 958:2002;321-324.
27. Zake L.N., Ghaderi M., Park Y.S., Babu S., Eisenbarth G., Sanjeevi C.B. MHC class I chain-related gene alleles 5 and 5.1 are transmitted more frequently to type 1 diabetes offspring in HBDI families. Ann N Y Acad Sci. 958:2002;309-311.
28. Wen L., Wong F.S., Tang J., Chen N.Y., Altieri M., David C., et al. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J Exp Med. 191:(1):2000;97-104.
29. Todd J.A., Bell J.I., McDevitt H.O. HLA-DQ beta gene contribution to susceptibility and resistance to insulin dependent diabetes mellitus. Nature. 329:1987;599-604.
30. Kwok W.W., Domeier M.E., Johnson M.L., Nepom G.T., Koelle D.M. HLA-DQB1 codon 57 is critical for peptide binding and recognition. J Exp Med. 183:(3):1996;1253-1258.
31. Sanjeevi C.B., Landin-Olsson M., Kockum I., Dahlquist G., Lernmark A. The combination of several polymorphic amino acid residues in the DQalpha and DQbeta chains forms a domain structure pattern and is associated with insulin-dependent diabetes mellitus. Ann N Y Acad Sci. 958:2002;362-375.
32. Khalil I., d'Auriol L., Gobet M., Morin L., Lepage V., Deschamps I., et al. A combination of HLA-DQB Asp57-negative and HLA-DQA Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest. 85:1990;1315-1319.
33. Lee K.H., Wucherpfennig K.W., Wiley D.C. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol. 2:(6):2001;501-507.
34. Pugliese A., Zeller M., Fernandez A.J., Zalcberg L.J., Bartlett R.J., Ricordi C., et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet. 15:(3):1997;293-297.
35. Vafiadis P., Bennett S.T., Todd J.A., Nadeau J., Grabs R., Goodyer C.G., et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet. 15:(3):1997;289-292.
36. *0602 allele. J Autoimmun. 9:(3):1996;423-425.
37. *0602 allele in unaffected, islet cell antibody-positive first degree relatives and in rare patients with type 1 diabetes. J Clin Endocrinol Metab. 84:(5):1999;1722-1728.
38. Tuomi T., Bjorses P., Falorni A., Partanen J., Perheentupa J., Lernmark A., et al. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type. I, J Clin Endocrinol Metab. 81:1996;1488-1494.
39. Pugliese A., Miceli D. The insulin gene in diabetes. Diabetes Metab Res Rev. 18:(1):2002;13-25.
40. Metcalfe K.A., Hitman G.A., Rowe R.E., Hawa M., Huang X., Stewart T., et al. Concordance for type 1 diabetes in identical twins is affected by insulin genotype. Diabetes Care. 24:(5):2001;838-842.
41. Bell G.I., Horita S., Karam J.H. A polymorphic locus near the human insulin gene is associated with insulin dependent diabetes mellitus. Diabetes. 33:1984;176-183.
42. Pugliese A., Awdeh Z.L., Alper C.A., Jackson R.A., Eisenbarth G.S. The paternally inherited insulin gene B allele (1,428 FokI site) confers protection from insulin-dependent diabetes in families. J Autoimmun. 7:1994;687-694.
43. Bennett S.T., Wilson A.J., Cucca F., Nerup J., Pociot F., McKinney P.A., et al. IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus. J Autoimmun. 9:(3):1996;415-421.
44. Bennett S.T., Lucassen A.M., Gough S.C., Powell E.E., Undlien D.E., Pritchard L.E., et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet. 9:(3):1995;284-292.
45. Stead J.D., Jeffreys A.J. Allele diversity and germline mutation at the insulin minisatellite. Hum Mol Genet. 9:(5):2000;713-723.
46. Stead J.D., Buard J., Todd J.A., Jeffreys A.J. Influence of allele lineage on the role of the insulin minisatellite in susceptibility to type 1 diabetes. Hum Mol Genet. 9:(20):2000;2929-2935.
47. Hammond-Kosack M.C., Docherty K. A consensus repeat sequence from the human insulin gene linked polymorphic region adopts multiple quadriplex DNA structures in vitro. FEBS Lett. 301:(1):1992;79-82.
48. Lew A., Rutter W.J., Kennedy G.C. Unusual DNA structure of the diabetes susceptibility locus IDDM2 and its effect on transcription by the insulin promoter factor Pur-1/MAZ. Proc Natl Acad Sci U S A. 97:(23):2000;12508-12512.
49. Sospedra M., Ferrer-Francesch X., Dominguez O., Juan M., Foz-Sala M., Pujol-Borrell R. Transcription of a broad range of self-antigens in human thymus suggests a role for central mechanisms in tolerance toward peripheral antigens. J Immunol. 161:(11):1998;5918-5929.
50. Pugliese A., Brown D., Garza D., Murchison D., Zeller M., Redondo M.J., et al. Self-antigen presenting cells expressing IDDM-associated autoantigens exist in both thymus and peripheral lymphoid organs in humans. J Clin Invest. 107:2001;585-593.
51. Pugliese A. Peripheral antigen-expressing cells and autoimmunity. Endocrinol Metab Clin North Am. 31:(2):2002;411-430.
52. Chentoufi A.A., Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes. 51:(5):2002;1383-1390.
53. Thebault-Baumont K., Dubois-Laforgue D., Krief P., Briand J.P., Halbout P., Vallon-Geoffroy K., et al. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest. 111:(6):2003;851-857.
54. French M.B., Allison J., Cram D.S., Thomas H.E., Dempsey-Collier M., Silva A., et al. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes. 46:(1):1997;34-39.
55. Nistico L., Buzzetti R., Pritchard L.E., Van der Auwera B., Giovannini C., Bosi E., et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet. 5:(7):1996;1075-1080.
56. Marron M.P., Raffel L.J., Garchon H.J., Jacob C.O., Serrano-Rios M., Martinez L.M., et al. Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. Hum Mol Genet. 6:(8):1997;1275-1282.
57. Awata T., Kurihara S., Iitaka M., Takei S., Inoue I., Ishii C., et al. Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves' disease and Hashimoto's thyroiditis) in the Japanese population. Diabetes. 47:(1):1998;128-129.
58. Marron M.P., Zeidler A., Raffel L.J., Eckenrode S.E., Yang J.J., Hopkins D.I., et al. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes. 49:(3):2000;492-499.
59. Ueda H., Howson J.M., Esposito L., Heward J., Snook H., Chamberlain G., et al. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature. 423:(6939):2003;506-511.
60. Hill N.J., Lyons P.A., Armitage N., Todd J.A., Wicker L.S., Peterson L.B. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes. 49:(10):2000;1744-1747.
61. Vadheim C.M., Rotter J.I., Maclaren N.K., Riley W.J., Anderson C.E. Preferential transmission of diabetic alleles within the HLA gene complex. N Engl J Med. 315:1986;1314-1318.
62. Deschamps I., Hors J., Clerget-Darpoux F., Gardais E., Robert J.J., Marcelli-Berge A., et al. Excess of maternal HLA-DR3 antigens in HLA DR3, 4 positive type 1 (insulin-dependent) diabetic patients. Diabetologia. 33:1990;425-439.
63. Bain S.C., Rowe B.R., Barnett A.H., Todd J.A. Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes. Diabetes. 43:1994;1462-1468.
64. Delepine M., Pociot F., Habita C., Hashimoto L., Froguel P., Rotter J., et al. Evidence of a non-MHC susceptibility locus in type I diabetes linked to HLA on chromosome 6. Am J Hum Genet. 60:(1):1997;174-187.
65. Wilkins J.F., Haig D. What good is genomic imprinting: the function of parent-specific gene expression. Nat Rev Genet. 4:(5):2003;359-368.
66. Giddings S.J., King C.D., Harman K.W., Flood J.F., Carnaghi L.R. Allele specific inactivation of insulin 1 and 2, in the mouse yolk, indicates imprinting. Nat Genet. 6:1994;310-313.
67. Polychronakos C., Vafiadis P., Giannoukakis N., Colle E. Imprinting and genotype-dependent gene expression at the IDDM2 locus in pancreas and lymphocytes. Autoimmunity. 21:(1):1995;16-17.
68. Moore G.E., Abu-Amero S.N., Bell G., Wakeling E.L., Kingsnorth A., Stanier P., et al. Evidence that insulin is imprinted in the human yolk sac. Diabetes. 50:(1):2001;199-203.
69. Bennett S.T., Wilson A.J., Esposito L., Bouzekri N., Undlien D.E., Cucca F., et al. Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele. The IMDIAB group. Nat Genet. 17:(3):1997;350-352.
70. Hollick J.B., Dorweiler J.E., Chandler V.L. Paramutation and related allelic interactions. Trends Genet. 13:(8):1997;302-308.
71. Duvillie B., Bucchini D., Tang T., Jami J., Paldi A. Imprinting at the mouse Ins2 locus: evidence for cis- and trans-allelic interactions. Genomics. 47:1998;52-57.
72. Diez J., Park Y., Zeller M., Brown D., Garza D., Ricordi C., et al. Differential splicing of the IA-2 mRNA in pancreas and lymphoid organs as a permissive genetic mechanism for autoimmunity against the IA-2 type 1 diabetes autoantigen. Diabetes. 50:(4):2001;895-900.